Gem Aromatics Limited, a manufacturer and exporter of essential oils and aromatic chemicals, has informed stock exchanges of a scheduled conference call with investors and analysts on Friday, May 22, 2026, at 4:00 PM IST. The disclosure was made pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call is intended to discuss the company's audited financial results for the quarter and year ended March 31, 2026.

Conference Call Details

The following key details have been provided for the Q4 & FY26 Earnings Call:

International Toll-Free Access

Participants from international locations can join the call using the following toll-free numbers:

• Hong Kong: 800964448
• Singapore: 8001012045
• UK: 08081011573
• USA: 18667462133

Management Representatives

The earnings call will be attended by the following members of the company's senior management:

Regulatory Disclosure

The intimation was filed by Akshita Deepak Gohil, Company Secretary & Compliance Officer of Gem Aromatics Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited on May 18, 2026. The company is headquartered at A/410-411, A-Wing, Kailash Ind. Complex, Powai Vikhroli Link Road, Vikhroli West, Mumbai – 400079, Maharashtra, India.

gem aromatics has successfully completed the utilization of its Initial Public Offer (IPO) proceeds as of the quarter ended March 31, 2026. The company submitted the final monitoring agency report to the stock exchanges on May 06, 2026, confirming that the gross proceeds of Rs 1,750.00 million have been fully deployed. The report, issued by CRISIL Ratings Limited, was prepared in compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Issue Details and Allocation

The IPO, which opened for subscription from August 19, 2025, to August 21, 2025, comprised equity shares with a total issue size of Rs 1,750.00 million. After deducting issue expenses amounting to Rs 121.37 million, the net proceeds available for deployment were Rs 1,628.63 million. The company allocated these funds towards specific objectives, including the repayment of borrowings and general corporate purposes.

Utilization of Proceeds

The primary object of the issue was the prepayment or repayment of outstanding borrowings availed by the company and its subsidiary, Krystal Ingredients Private Limited. A total of Rs 1,400.00 million was utilized for this purpose. Additionally, funds were allocated to general corporate purposes and issue expenses. The actual issue expenses were lower than estimated, resulting in a saving of Rs 4.58 million, which was subsequently added to the general corporate purposes allocation. The following table summarizes the revised and actual utilization of IPO proceeds:

Monitoring Agency Observations

CRISIL Ratings Limited, acting as the monitoring agency, confirmed that there were no deviations from the objects stated in the offer document. The agency verified the utilization based on a management undertaking, statutory auditor certificates dated April 20, 2026 issued by Chhajed & Doshi, Chartered Accountants, and bank statements. The report highlighted that the amount utilized for general corporate purposes did not exceed 25% of the gross proceeds. As of March 31, 2026, the IPO public issue account and monitoring account balances were nil, indicating the complete deployment of funds.

The board of directors approved the utilization of funds for general corporate purposes towards meeting expenses incurred in the ordinary course of business, including vendor payments for raw materials, via a resolution dated May 05, 2026. The following table details the quarter-wise progress in utilization of IPO proceeds:

With the full utilization of proceeds, this monitoring agency report serves as the final submission regarding the IPO fund deployment for Gem Aromatics Limited.